The discriminative capacity of CSF β-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population
Abstract
Introduction In the past few years, the β-amyloid 42 peptide and tau protein in cerebrospinal fluid (CSF) have become primary diagnostic biomarkers in differentiating Alzheimer's disease (AD) and cognitive normal controls. As we know, several neurodegenerative diseases have been reported to overlap with AD in neuropathology and clinical symptoms. To examine the discriminative utility of these biomarkers in AD and other neurodegenerative...
Paper Details
Title
The discriminative capacity of CSF β-amyloid 42 and Tau in neurodegenerative diseases in the Chinese population
Published Date
May 1, 2020
Volume
412
Pages
116756 - 116756
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History